pharmaceutical-investing MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
pharmaceutical-investing Supernus Announces First Quarter 2018 Financial Results and Record Quarterly Revenue
pharmaceutical-investing Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update
Arch Biopartners Completes Pre-IND Meeting with U.S. FDA on LSALT Peptide for Preventing Acute Kidney Injury in Cardiac Surgery Patients
pharmaceutical-investing Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
pharmaceutical-investing Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
pharmaceutical-investing Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress
Koios Beverage Corp. Announces Final Bulletin and Trading Date in Connection with Fundamental Change Transaction
medical-device-investing Medtronic Announces FDA Approval of Infuse Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants
pharmaceutical-investing Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia
